InVent Life Sciences, LLC provides professional management to start-ups looking to commercialize Life Science technology. As serial entrepreneurs, we have built a commercialization model that leverages a valuable network. Together, a cost effective, risk-adverse product or device validation model is achieved.
Translating biotechnology out of a research environment and into an effective industry strategy - presents challenges of every kind. InVent Life Sciences has developed TekniGROW™, a highly structured and effective program to minimize risk, cost and effort. TekniGROW™ focuses resources on milestones that will position the technology to be noticed by Industry.
Currently, we have a number of promising technologies which we are commercializing:
ILS-01: Biomarker for early detection of Alzheimer's Disease
ILS-02: Immunosignature based drug discovery for Brain Cancer.
ILS-03: Three-dimensional Tissue Engineering to model complex diseased tissue.
ILS-04:Innovative orthopedic material for applications as a bone filler or vertebroplasty.
ILS-05: Too new to announce yet. Stay tuned